A tissue microarray (TMA) cohort of all CCA patients who underwent surgical resection with curative intent between August 2005 and December 2021 at University Hospital Frankfurt were immunohistochemically evaluated using the VENTANA® CLDN18 (43‐14A) antibody. The gene discussed is CLDN18; the disease is cholangiocarcinoma.